Who owns the KENOX PHARMACEUTICALS trademark?

The KENOX PHARMACEUTICALS trademark is owned by Kenox Pharmaceuticals Inc..

What class is the KENOX PHARMACEUTICALS trademark registered in?

The KENOX PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for KENOX PHARMACEUTICALS?

The USPTO serial number for KENOX PHARMACEUTICALS is 97436436.

What is the registration number for KENOX PHARMACEUTICALS?

KENOX PHARMACEUTICALS is registered under USPTO registration number 7627008.

KEN

USPTO Trademark Record

REGISTERED

KENOX PHARMACEUTICALS

SN 97436436·Reg 7627008·Filed May 31, 2022

Owner Kenox Pharmaceuticals Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

KENOX PHARMACEUTICALS (Serial No. 97436436), Registration No. 7627008, is a registered US trademark filed on May 31, 2022 by Kenox Pharmaceuticals Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: December 24, 2030

Mark Intelligence

KENOX PHARMACEUTICALS (Reg. #7627008) is a registered US trademark that has been protecting its owner, Kenox Pharmaceuticals Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 31, 2022

SERIAL

97436436

REG#

7627008

REGISTERED

Dec 24, 2024

Owner

Applicant

Kenox Pharmaceuticals Inc.

Entity

Corporation

State

Address

285 Durham Ave., Suite #11, South Plainfield, NJ, 07080

Country

Attorney

NameY. Jae Kim

Law firm

Y. Jae Kim KIM IP LAW GROUP LLC

Docket

6107.0008

Address

129 W. EVESHAM ROAD, VOORHEES, NJ 08043, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 31, 2022

Serial Number97436436

Registration No.7627008

Registration DateDec 24, 2024

Status DateDec 24, 2024

Published for OppositionJul 11, 2023

Mark TypeDesign with words

Attorney Docket6107.0008

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 01, 2019

First use in commerce: Oct 01, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

32 events

REGISTERED-PRINCIPAL REGISTER

Dec 24, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 24, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 25, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 25, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

SU-EXAMINER'S AMENDMENT WRITTEN

Oct 01, 2024

SU-EXAMINER'S AMENDMENT WRITTEN

EXAMINERS AMENDMENT E-MAILED

Oct 01, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 01, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Oct 01, 2024

EXAMINER'S AMENDMENT ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 02, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 02, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

SU - NON-FINAL ACTION - WRITTEN

Feb 22, 2024

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Feb 22, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 22, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 26, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jan 26, 2024

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Jan 05, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Jan 05, 2024

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 05, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 11, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 11, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 21, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 07, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 02, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 01, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 01, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

ASSIGNED TO EXAMINER

Mar 16, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Mar 16, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 16, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 16, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jun 08, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 07, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 03, 2022

NEW APPLICATION ENTERED

KENOX PHARMACEUTICALS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Kenox Pharmaceuticals Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Y. Jae Kim

Resources

Company